Apogee Therapeutics, Inc. — All Filings
242 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-25-273250 | Nov 10, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-273260 | Nov 10, 2025 | Sep 30, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-108652 | Nov 7, 2025 | Nov 5, 2025 |
| 144 | — | 0001950047-25-008475 | Nov 5, 2025 | — |
| 4 | — | 0001698082-25-000003 | Oct 15, 2025 | Oct 10, 2025 |
| SCHEDULE 13D/A | — | 0001104659-25-099401 | Oct 14, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-098487 | Oct 10, 2025 | Oct 8, 2025 |
| 424B5 | 424B5 | 0001104659-25-098480 | Oct 10, 2025 | — |
| 424B5 | 424B5 | 0001104659-25-097972 | Oct 8, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-096792 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-087939 | Sep 5, 2025 | Sep 3, 2025 |
| 8-K | 8-K | 0000950170-25-106228 | Aug 11, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-106234 | Aug 11, 2025 | Jun 30, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-075801 | Aug 8, 2025 | Aug 6, 2025 |
| SCHEDULE 13G/A | — | 0000315066-25-001957 | Aug 6, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000262 | Aug 5, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000264 | Aug 5, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-002476 | Jul 16, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-065926 | Jul 7, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-065888 | Jul 3, 2025 | Jul 2, 2025 |
| 144 | — | 0001950047-25-004802 | Jul 2, 2025 | — |
| 8-K | 8-K | 0000950170-25-088600 | Jun 23, 2025 | Jun 17, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-061278 | Jun 20, 2025 | Jun 17, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-061272 | Jun 20, 2025 | Jun 17, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-061274 | Jun 20, 2025 | Jun 17, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-061273 | Jun 20, 2025 | Jun 17, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-061275 | Jun 20, 2025 | Jun 17, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-061276 | Jun 20, 2025 | Jun 17, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-061277 | Jun 20, 2025 | Jun 17, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-057468 | Jun 6, 2025 | Jun 4, 2025 |
| SCHEDULE 13G/A | — | 0000902219-25-000171 | May 12, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-046955 | May 12, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-068513 | May 12, 2025 | Mar 31, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-046896 | May 9, 2025 | May 7, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-060166 | Apr 29, 2025 | — |
| ARS | ARS | 0000950170-25-060328 | Apr 29, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0000950170-25-060147 | Apr 29, 2025 | Jun 17, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-032308 | Apr 4, 2025 | Apr 2, 2025 |
| 144 | — | 0001950047-25-002330 | Apr 2, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-022371 | Mar 11, 2025 | Mar 10, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-021861 | Mar 7, 2025 | Mar 5, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-021862 | Mar 7, 2025 | Mar 5, 2025 |
| 144 | — | 0001000275-25-000047 | Mar 5, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-019467 | Mar 3, 2025 | — |
| 10-K | 10-K | 0000950170-25-030385 | Mar 3, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0001104659-25-019460 | Mar 3, 2025 | — |
| SCHEDULE 13G | — | 0000950170-25-020483 | Feb 14, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-010642 | Feb 7, 2025 | Feb 5, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-010645 | Feb 7, 2025 | Feb 5, 2025 |
| 144 | — | 0001000275-25-000014 | Feb 5, 2025 | — |